Home
>
National Drug Code (NDC)
>
Novolin
Novolin - 0169-1837-11 - (Human Insulin)
Drug Information of Novolin
| Product NDC: | 0169-1837 |
| Proprietary Name: | Novolin |
| Non Proprietary Name: | Human Insulin |
| Active Ingredient(s): | 100 [USP'U]/mL & nbsp; Human Insulin |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Novolin
| Product NDC: | 0169-1837 |
| Labeler Name: | Novo Nordisk |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA019991 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19910625 |
Package Information of Novolin
| Package NDC: | 0169-1837-11 |
| Package Description: | 1 VIAL in 1 CARTON (0169-1837-11) > 10 mL in 1 VIAL |
NDC Information of Novolin
| NDC Code | 0169-1837-11 |
| Proprietary Name | Novolin |
| Package Description | 1 VIAL in 1 CARTON (0169-1837-11) > 10 mL in 1 VIAL |
| Product NDC | 0169-1837 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Human Insulin |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 19910625 |
| Marketing Category Name | NDA |
| Labeler Name | Novo Nordisk |
| Substance Name | INSULIN HUMAN |
| Strength Number | 100 |
| Strength Unit | [USP'U]/mL |
| Pharmaceutical Classes |
